Repligen (RGEN) PT Lowered to $145 at Canaccord
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq eyes lower open after midterms-fueled surge as chip, data center stocks fall
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Apple seeks to raise up to $7 billion in seven-tranche bond offering
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $178.20 --0%
Rating Summary:
23 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 20 | Down: 37 | New: 6
Rating Summary:
23 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 20 | Down: 37 | New: 6
Join SI Premium – FREE
Canaccord analyst Kyle Mikson lowered the price target on Repligen (NASDAQ: RGEN) to $145.00 (from $165.00) while maintaining a Hold rating.
You May Also Be Interested In
- Hut 8 Mining Corp. (HUT) PT Lowered to $127 at Cantor Fitzgerald
- McKesson (MCK) PT Raised to $1,200 at TD Cowen
- Myriad Genetics (MYGN) PT Raised to $6.75 at TD Cowen
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
